These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5950551)

  • 1. Clinical experiences with a potent new corticosteroid ester for dermatoses. Report describing a preliminary clinical study of bethamethasone, a new, active topical corticosteroid.
    Luscombe HA
    Pa Med; 1966 Oct; 69(10):48-9. PubMed ID: 5950551
    [No Abstract]   [Full Text] [Related]  

  • 2. A new, highly potent corticosteroid ester for dermatoses. Favorable response is demonstrated with bethamethasone 17-valerate treatment in a select patient group.
    Goldblum RW
    Pa Med; 1966 Oct; 69(10):50-2. PubMed ID: 5917957
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind clinical comparisons of topical betamethasone valerate and betamethasone benzoate in the treatment of steroid-responsive dermatoses.
    Hall-Smith P
    Br J Clin Pract; 1972 Sep; 26(9):422-3. PubMed ID: 4562674
    [No Abstract]   [Full Text] [Related]  

  • 4. Betamethasone 17-valerate. A custom-made topical corticosteroid.
    Zimmerman EH
    Arch Dermatol; 1967 May; 95(5):514-9. PubMed ID: 6023706
    [No Abstract]   [Full Text] [Related]  

  • 5. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Betamethasone valerate, a new corticoid for topical use in dermatology].
    Cordero AA
    Prensa Med Argent; 1965 Jun; 52(21):1365-9. PubMed ID: 5845351
    [No Abstract]   [Full Text] [Related]  

  • 7. Desoximetasone: a new topical corticosteroid. Clinical evaluation.
    Mitra SC; Banerjee HP
    Indian J Dermatol; 1974 Oct; 20(1):7-15. PubMed ID: 4615062
    [No Abstract]   [Full Text] [Related]  

  • 8. [Controlled experimentation on the therapeutic effect of 2 topical anti-inflammatory steroids].
    Carbone G; Massone L
    Arch Ital Dermatol Venereol Sessuol; 1970; 36(3):207-14. PubMed ID: 4919648
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians.
    Fleischer AB; Feldman SR
    Clin Ther; 1999 Oct; 21(10):1725-31. PubMed ID: 10566568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trials in various dermatoses, with a new topical corticoid-anti-infective agent combination].
    Morán M; Pérez AG
    Actas Dermosifiliogr; 1975; 66(1-2):37-44. PubMed ID: 1146626
    [No Abstract]   [Full Text] [Related]  

  • 11. [Halometasone, a new topical corticosteroid, in dermatological practice].
    Cimitan A; Pincelli C; Pincelli L
    G Ital Dermatol Venereol; 1984; 119(2):V-VIII. PubMed ID: 6735440
    [No Abstract]   [Full Text] [Related]  

  • 12. [A clinical trial of a new class IV corticosteroid for topical use. Fifty-two case-reports (author's transl)].
    Daniel F
    Sem Hop; 1981 Oct 8-15; 57(37-38):1537-41. PubMed ID: 6270823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in using the 2 levels of concentration of Betnevate N cream (betamethasone 17-valerate with Fradiomycin sulfate)].
    Shimizu M; Morito S; Kawamura Y
    Hifuka Kiyo; 1970 Aug; 65(2):95-102. PubMed ID: 5533829
    [No Abstract]   [Full Text] [Related]  

  • 14. Summary of clinical experience with a new ester of betamethasone--the valerate (valisone ointment).
    Nierman MM
    J Indiana State Med Assoc; 1966 Oct; 59(10):1184-6. PubMed ID: 5978360
    [No Abstract]   [Full Text] [Related]  

  • 15. Betamethasone dipropionate and salicylic acid lotion for nonscalp dermatoses.
    Malfitan VA
    Clin Ther; 1983; 5(3):290-8. PubMed ID: 6850723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of a new corticosteroid for dermatologic use: betamethasone 17-valerate].
    Témime P; Privat Y
    Sem Hop; 1965 May; 41(25):1523-5. PubMed ID: 4284389
    [No Abstract]   [Full Text] [Related]  

  • 19. [Flubenisolonvalerate and fluocinolonacetonide in the treatment of skin diseases. A double-blind study].
    Thomsen K
    Ugeskr Laeger; 1966 Nov; 128(47):1391-3. PubMed ID: 5342507
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preliminary results of the use of Celestamin in some dermatoses].
    Giuliani V
    Minerva Dermatol; 1967 Apr; 42(4):149-52. PubMed ID: 4387074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.